NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

COR

Cencora Inc

Jun 24 • 02:54PM ET

293.40

Dollar change +0.27
Percentage change 0.09	%

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO SPY IVV VTV XLV USMV VOE IWP

Scroll to Statements

Index	S&P 500	P/E	34.05	EPS (ttm)	8.62	Insider Own	5.34%	Shs Outstand	193.78M	Perf Week	0.31%
Market Cap	56.87B	Forward P/E	16.89	EPS next Y	17.38	Insider Trans	-11.85%	Shs Float	183.48M	Perf Month	1.13%
Enterprise Value	62.78B	PEG	2.93	EPS next Q	3.82	Inst Own	93.59%	Short Float	3.58%	Perf Quarter	9.68%
Income	1.69B	P/S	0.18	EPS this Y	14.97%	Inst Trans	1.78%	Short Ratio	3.80	Perf Half Y	29.26%
Sales	310.23B	P/B	56.14	EPS next Y	9.84%	ROA	2.51%	Short Interest	6.57M	Perf YTD	30.59%
Book/sh	5.23	P/C	26.95	EPS next 5Y	11.62%	ROE	161.58%	52W High	309.35 -5.16%	Perf Year	24.49%
Cash/sh	10.89	P/FCF	15.91	EPS past 3/5Y	0.66% 13.29%	ROIC	20.91%	52W Low	218.65 34.19%	Perf 3Y	108.14%
Dividend Est.	2.20 (0.75%)	EV/EBITDA	14.66	Sales past 3/5Y	11.16% 10.36%	Gross Margin	2.94%	Volatility	0.93% 1.02%	Perf 5Y	192.96%
Dividend TTM	2.16 (0.74%)	EV/Sales	0.20	EPS Y/Y TTM	-5.92%	Oper. Margin	1.03%	ATR (14)	5.42	Perf 10Y	163.90%
Dividend Ex-Date	May 16, 2025	Quick Ratio	0.52	Sales Y/Y TTM	12.18%	Profit Margin	0.55%	RSI (14)	54.86	Recom	1.78
Dividend Gr. 3/5Y	5.04% 4.98%	Current Ratio	0.87	EPS Q/Q	75.92%	SMA20	0.78%	Beta	0.57	Target Price	335.77
Payout	27.07%	Debt/Eq	7.76	Sales Q/Q	10.29%	SMA50	1.55%	Rel Volume	0.34	Prev Close	293.13
Employees	46000	LT Debt/Eq	7.00	Earnings	May 07 BMO	SMA200	15.14%	Avg Volume	1.73M	Price	293.40
IPO	Apr 04, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.42% -0.24%	Trades		Volume	487,847	Change	0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106

Show Previous Ratings

Today 09:33AM	Should You Continue to Retain Abbott Stock in Your Portfolio Now? (Zacks)
08:35AM	Is This the Right Time to Hold EYE Stock in Your Portfolio? (Zacks)
Jun-23-25 09:50AM	TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 + (Zacks)
Jun-19-25 08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
08:18AM	ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise? (Zacks)
08:17AM	Loading…
08:17AM	Should You Add NVST Stock to Your Portfolio Right Now? (Zacks)
Jun-18-25 09:22AM	Reasons to Add PAHC Stock to Your Portfolio Right Now (Zacks)
08:28AM	Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? (Zacks)
Jun-17-25 08:39AM	DGX Stock Up on New Blood Test Development Deal With MD Anderson (Zacks)
Jun-16-25 11:19AM	GEHC Stock Declines Despite Expansion in Precision Care Capabilities (Zacks)
08:35AM	Take the Zacks Approach to Beat the Markets: Mirion Technologies, Avino Silver & Gold Mines, Quanta Services in Focus (Zacks)
08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
Jun-11-25 08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
04:29AM	Loading…
04:29AM	COR Q1 Earnings Call: Specialty Expansion, RCA Impact, and International Softness Highlight Results (StockStory)
Jun-10-25 08:06AM	Bruker Stock Set to Gain From Acquisition of Austria's biocrates (Zacks)
Jun-09-25 06:20AM	Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? (Zacks)
Jun-05-25 12:26PM	ECL Stock Gains Following Latest Launch to Boost Data Center Cooling (Zacks)
08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
06:20AM	Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now? (Zacks)
Jun-04-25 12:33PM	HIMS Stock Falls Despite Latest Deal to Expand International Footprint (Zacks)
08:34AM	Should You Continue to Hold Labcorp Stock in Your Portfolio? (Zacks)
Jun-03-25 08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
Jun-02-25 09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
May-30-25 09:32AM	COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down (Zacks)
09:31AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
May-29-25 09:29AM	Reasons to Retain The Cooper Companies Stock in Your Portfolio Now (Zacks)
May-28-25 12:18PM	Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer (Zacks)
09:14AM	Loading…
09:14AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
07:30AM	Cencora Elects Lori J. Ryerkerk to Its Board of Directors (Business Wire)
May-27-25 09:08AM	Beat the Market the Zacks Way: GE Aerospace, Monster Beverage, Cencora in Focus (Zacks)
May-23-25 04:03PM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
10:47AM	RVTY Stock Falls Despite the Latest Launch of Automated Instrument (Zacks)
06:20AM	Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar? (Zacks)
May-22-25 09:54AM	Here's Why Investors Should Consider Retaining Danaher Stock Now (Zacks)
06:20AM	Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? (Zacks)
May-21-25 01:08PM	MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio (Zacks)
07:17AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
06:20AM	Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now? (Zacks)
May-19-25 09:58AM	Robust Results Lifted Cencora (COR) Amid Upgraded Outlook (Insider Monkey)
07:02AM	Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now (Zacks)
06:54AM	MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now? (Zacks)
May-18-25 06:56AM	Jim Cramer Highlights Cencora (COR) "Knocked It Out of The Park" (Insider Monkey)
May-16-25 08:00AM	Here's Why You Should Add DexCom Stock to Your Portfolio Now (Zacks)
07:59AM	Doximity Stock Plunges Despite Q4 Earnings & Sales Beat, Margins Up (Zacks)
06:20AM	Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? (Zacks)
May-14-25 06:20AM	Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar? (Zacks)
May-12-25 08:01AM	Beat the Market the Zacks Way: Limbach, Stride, Cencora in Focus (Zacks)
May-09-25 09:50AM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
May-08-25 05:05PM	S&P 500 Gains and Losses Today: Axon Enterprise Soars as Software Demand Drives Earnings Beat (Investopedia) -6.83%
09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
May-07-25 05:00PM	Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
03:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
01:25PM	Jim Cramer on Cencora, Inc. (COR): 'Middleman Money Machine Silences the Doubters' (Insider Monkey)
01:25PM	Jim Cramer on Cencora (COR): "Middleman Money Machine Silences the Doubters" (Insider Monkey)
01:09PM	COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised (Zacks)
10:57AM	Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth (Seeking Alpha)
10:55AM	Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:40AM	Has BrightSpring Health Services, Inc. (BTSG) Outpaced Other Medical Stocks This Year? (Zacks)
07:40AM	Cencora (COR) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:30AM	Cencora Reports Fiscal 2025 Second Quarter Results (Business Wire)
May-06-25 10:13AM	MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN (Zacks)
06:20AM	Is First Trust Growth Strength ETF (FTGS) a Strong ETF Right Now? (Zacks)
May-05-25 11:12AM	DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock? (Zacks)
07:25AM	Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates? (Zacks)
May-02-25 09:00PM	LRT Capital Management April 2025 Investor Update (Seeking Alpha)
11:05AM	Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings? (Zacks)
09:15AM	Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-30-25 10:17AM	Will Declining Medical Customers Affect Cigna's Q1 Earnings? (Zacks)
10:01AM	Cencora (COR) Earnings Expected to Grow: Should You Buy? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-28-25 12:23PM	Can Humana Beat Q1 Earnings Estimates on Growing Premiums? (Zacks)
11:22AM	Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings? (Zacks)
09:12AM	Here's How Charles River is Placed Just Ahead of Q1 Earnings (Zacks)
08:45AM	GYN Surgical Division Likely to Drive Hologic's Q2 Earnings (Zacks)
08:08AM	Beat the Market the Zacks Way: ProAssurance, Stride, Hershey in Focus (Zacks)
01:55AM	CHGX: Equal-Weight ESG ETF (Seeking Alpha)
Apr-25-25 08:02AM	Cencora (COR) Surged on Strong Returns (Insider Monkey)
08:00AM	Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely? (Zacks)
Apr-24-25 06:14PM	TimesSquare U.S. Focus Growth Q1 2025 Commentary (Seeking Alpha)
02:50PM	TimesSquare U.S. Mid Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
11:00AM	Universal Health to Report Q1 Earnings: Can it Surprise Wall Street? (Zacks)
Apr-23-25 01:41PM	HCA Healthcare to Report Q1 Earnings: Key Estimates to Note (Zacks)
01:28PM	Can Centene Beat Q1 Earnings Estimates on Growing Premiums? (Zacks)
Apr-22-25 11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
11:19AM	Molina Healthcare to Report Q1 Earnings: Key Estimates to Watch (Zacks)
Apr-21-25 09:40AM	Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year? (Zacks)
06:20AM	Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar? (Zacks)
Apr-17-25 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:52AM	3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes (Zacks)
09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-16-25 12:53PM	Jim Cramer: Cencora (COR) Is a "Must-Own" Drug Middleman - Even If It Should Be Digitized Away (Insider Monkey)
Apr-15-25 02:30AM	FTCS: Unconvincing Quality-Focused ETF (Seeking Alpha)
Apr-14-25 09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:02AM	Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus (Zacks)
Apr-13-25 05:43PM	Jim Cramer Likes Cencora (COR) "Middlemen Always Work." (Insider Monkey)
Apr-10-25 09:02AM	Cencora, Inc. (COR): A Bull Case Theory (Insider Monkey)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COLLIS STEVEN H	Director	Jun 24 '25	Proposed Sale	292.62	14,579	4,266,107		Jun 24 10:21 AM
Battaglia Silvana	Executive Vice President	Jun 18 '25	Sale	297.40	4,077	1,212,520	11,297	Jun 20 04:06 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Option Exercise	86.09	3,225	277,640	49,063	Jun 20 04:04 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Sale	295.30	4,969	1,467,346	44,094	Jun 20 04:04 PM
Lon Greenberg	Board of directors	Jun 18 '25	Proposed Sale	293.20	1,000	293,200		Jun 18 04:40 PM
Battaglia Silvana	Officer	Jun 18 '25	Proposed Sale	297.41	4,077	1,212,520		Jun 18 12:58 PM
Mauch Robert P.	Officer	Jun 18 '25	Proposed Sale	295.30	4,969	1,467,346		Jun 18 09:50 AM
Krikorian Lazarus	SVP & Chief Accounting Officer	May 29 '25	Sale	288.96	3,000	866,881	17,154	Jun 02 04:08 PM
Krikorian Lazarus	Officer	May 29 '25	Proposed Sale	288.96	3,000	866,881		May 29 11:37 AM
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 06 '25	Sale	244.51	1,286,376	314,531,796	12,570,000	Feb 10 07:35 PM
Walgreens Boots Alliance Holdi	Affiliate	Feb 06 '25	Proposed Sale	246.13	1,081,885	266,284,355		Feb 06 07:55 PM
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Option Exercise	89.58	10,754	963,343	295,842	Aug 21 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Sale	239.13	10,754	2,571,604	285,088	Aug 21 04:08 PM
COLLIS STEVEN H	Officer	Aug 20 '24	Proposed Sale	239.13	10,754	2,571,604		Aug 20 10:47 AM
Battaglia Silvana	Executive Vice President	Aug 06 '24	Sale	242.69	1,473	357,482	10,948	Aug 07 04:09 PM
Battaglia Silvana	Officer	Aug 06 '24	Proposed Sale	242.69	1,473	357,483		Aug 06 02:08 PM
Walgreens Boots Alliance, Inc.	10% Owner	Aug 01 '24	Sale	240.56	4,438,171	1,067,646,416	19,980,000	Aug 05 06:44 PM
Walgreens Boots Alliance Holdi	Affiliate	Aug 01 '24	Proposed Sale	244.46	3,398,929	830,902,183		Aug 01 08:56 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Option Exercise	89.58	10,755	963,433	295,843	Jul 17 04:09 PM
COLLIS STEVEN H	Chairman, President & CEO	Jul 16 '24	Sale	222.12	10,755	2,388,901	285,088	Jul 17 04:09 PM
Donato Leslie E	EVP & Chief Strategy Officer	Jul 01 '24	Option Exercise	0.00	1,432	0	9,991	Jul 02 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your FINVIZ experience